Osteoarthritic Tarsometatarsal Joint Treatment

12 Year old Warmblood Gelding:

Devon was a 12-year-old Warmblood gelding that was competing at level 5 dressage. Over the space of three months his ability to perform flying changes to the left significantly reduced and his willingness to conduct upwards, transitions deteriorated.

Joint Lameness:

Physical examination found the horse to be 3/5 lame in the left hind leg, which was isolated to the tarsometatarsal (lower hock) joint with diagnostic analgesia. Radiographs were taken and found there to be mild osteoarthritic change on the front of the tarsometatarsal joint, with there being a reduction in bone density and slight spur development, which is shown in the image, left, within the green circle.

Treatment and Outcome: 

1ml of Arthramid® Vet was injected into the joint and the horse was then rested for 48 hours before commencing an ascending exercise program over two weeks to return to a full exercise regime. Over the space of four weeks, the clinical signs dissipated with the horse willingly and comfortably able to perform all movements asked of it. Devon was injected eight months previously and continues to show no recurrence of clinical signs of pain and has one delighted owner as a result.

Arthramid Hydrogel
About

Learn More

Case Selection & Management
FAQ

Learn More

Clinical Studies
CaseStudies

Learn More

Contact Us

Get In Touch

First Name:
Last Name:
Your Email:
Phone:
Business Name:
Subject:

32 Hill Road, Cambridge, NZ Phone +64 (09) 8013 253 sales@imsvet.com

Arthramid Vet New Zealand

Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz  for registration conditions.

32 Hill Road, Cambridge
PO Box 1083, Cambridge 3450
Phone +64 (027) 281 4329
Contact@imsvet.com